Email
Print
Radiopharmaceuticals/ Nuclear Medicine Market - Forecast(2024 - 2030)
1. Radiopharmaceuticals/ Nuclear Medicine Market - Overview
1.1 Definitions and Scope
2. Radiopharmaceuticals/ Nuclear Medicine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Radiopharmaceuticals/ Nuclear Medicine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Radiopharmaceuticals/ Nuclear Medicine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Radiopharmaceuticals/ Nuclear Medicine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Radiopharmaceuticals/ Nuclear Medicine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Radiopharmaceuticals/ Nuclear Medicine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Radiopharmaceuticals/ Nuclear Medicine Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Diagnostic Nuclear Medicine
8.2.1 Spect Radiopharmaceuticals
8.2.1.1 Tc-99m
8.2.1.2 Tl-201
8.2.1.3 Ga-67
8.2.1.4 I-123
8.2.1.5 Other Spect Isotopes
8.2.2 Pet Radiopharmaceuticals
8.2.2.1 F-18
8.2.2.2 Ru-82
8.2.2.3 Other Pet Isotopes
8.3 Therapeutic Nuclear Medicine
8.3.1 Alpha Emitters
8.3.1.1 Ra-223
8.3.2 Beta Emitters
8.3.2.1 I-131
8.3.2.2 Y-90
8.3.2.3 Sm-153
8.3.2.4 Re-186
8.3.2.5 Lu-177
8.3.2.6 Other Beta Emitters
8.3.3 Brachytherapy Isotopes
8.3.3.1 I-125
8.3.3.2 Ir-192
8.3.3.3 Pd-103
8.3.3.4 Cs-131
8.3.3.5 Other Brachytherapy Isotopes
9. Radiopharmaceuticals/ Nuclear Medicine Market - By Procedural Volume (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Diagnostic Procedures
9.2.1 Spect Radiopharmaceuticals
9.2.2 Pet Radiopharmaceuticals
9.3 Therapeutic Procedures
9.3.1 Beta Emitters
9.3.2 Alpha Emitters
9.3.3 Brachytherapy Isotopes
10. Radiopharmaceuticals/ Nuclear Medicine - By Application (Market Size -$Million / $Billion)
10.1 Introduction
10.2 Diagnostic Applications
10.2.1 Spect Applications
10.2.1.1 Cardiology
10.2.1.2 Lymphoma
10.2.1.3 Neurology
10.2.1.4 Thyroid
10.2.1.5 Other Spect Applications
10.2.2 Pet Applications
10.2.2.1 Oncology
10.2.2.2 Cardiology
10.2.2.3 Neurology
10.2.2.4 Other Pet Applications
10.3 Therapeutic Applications
10.3.1 Thyroid
10.3.2 Bone Metastasis
10.3.3 Lymphoma
10.3.4 Endocrine Tumors
10.3.5 Other Therapeutic Applications
11. Radiopharmaceuticals/ Nuclear Medicine- By Geography (Market Size -$Million / $Billion)
11.1 Radiopharmaceuticals/ Nuclear Medicine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Radiopharmaceuticals/ Nuclear Medicine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Radiopharmaceuticals/ Nuclear Medicine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Radiopharmaceuticals/ Nuclear Medicine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Radiopharmaceuticals/ Nuclear Medicine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Radiopharmaceuticals/ Nuclear Medicine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Radiopharmaceuticals/ Nuclear Medicine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Radiopharmaceuticals/ Nuclear Medicine Market - Key Company List by Country Premium
15. Radiopharmaceuticals/ Nuclear Medicine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Advanced Accelerator Application
15.3 Bayer
15.4 Bracco Imaging
15.5 Cardinal Health
15.6 Curium
15.7 Eczacibasi-Monrol Nuclear Product
15.8 Ge Healthcare
15.9 Lantheus Medical Imaging
15.10 Nordion
15.11 Company 10
15.12 Company 11 & More
16.1 Abbreviations
16.2 Sources
17. Radiopharmaceuticals/ Nuclear Medicine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Radiopharmaceuticals/ Nuclear Medicine Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Radiopharmaceuticals/ Nuclear Medicine Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Radiopharmaceuticals/ Nuclear Medicine Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Radiopharmaceuticals/ Nuclear Medicine Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Radiopharmaceuticals/ Nuclear Medicine Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Radiopharmaceuticals/ Nuclear Medicine Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Radiopharmaceuticals/ Nuclear Medicine Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Diagnostic Nuclear Medicine
8.2.1 Spect Radiopharmaceuticals
8.2.1.1 Tc-99m
8.2.1.2 Tl-201
8.2.1.3 Ga-67
8.2.1.4 I-123
8.2.1.5 Other Spect Isotopes
8.2.2 Pet Radiopharmaceuticals
8.2.2.1 F-18
8.2.2.2 Ru-82
8.2.2.3 Other Pet Isotopes
8.3 Therapeutic Nuclear Medicine
8.3.1 Alpha Emitters
8.3.1.1 Ra-223
8.3.2 Beta Emitters
8.3.2.1 I-131
8.3.2.2 Y-90
8.3.2.3 Sm-153
8.3.2.4 Re-186
8.3.2.5 Lu-177
8.3.2.6 Other Beta Emitters
8.3.3 Brachytherapy Isotopes
8.3.3.1 I-125
8.3.3.2 Ir-192
8.3.3.3 Pd-103
8.3.3.4 Cs-131
8.3.3.5 Other Brachytherapy Isotopes
9. Radiopharmaceuticals/ Nuclear Medicine Market - By Procedural Volume (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Diagnostic Procedures
9.2.1 Spect Radiopharmaceuticals
9.2.2 Pet Radiopharmaceuticals
9.3 Therapeutic Procedures
9.3.1 Beta Emitters
9.3.2 Alpha Emitters
9.3.3 Brachytherapy Isotopes
10. Radiopharmaceuticals/ Nuclear Medicine - By Application (Market Size -$Million / $Billion)
10.1 Introduction
10.2 Diagnostic Applications
10.2.1 Spect Applications
10.2.1.1 Cardiology
10.2.1.2 Lymphoma
10.2.1.3 Neurology
10.2.1.4 Thyroid
10.2.1.5 Other Spect Applications
10.2.2 Pet Applications
10.2.2.1 Oncology
10.2.2.2 Cardiology
10.2.2.3 Neurology
10.2.2.4 Other Pet Applications
10.3 Therapeutic Applications
10.3.1 Thyroid
10.3.2 Bone Metastasis
10.3.3 Lymphoma
10.3.4 Endocrine Tumors
10.3.5 Other Therapeutic Applications
11. Radiopharmaceuticals/ Nuclear Medicine- By Geography (Market Size -$Million / $Billion)
11.1 Radiopharmaceuticals/ Nuclear Medicine Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Radiopharmaceuticals/ Nuclear Medicine- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Radiopharmaceuticals/ Nuclear Medicine- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Radiopharmaceuticals/ Nuclear Medicine - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Radiopharmaceuticals/ Nuclear Medicine - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Radiopharmaceuticals/ Nuclear Medicine Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Radiopharmaceuticals/ Nuclear Medicine Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Radiopharmaceuticals/ Nuclear Medicine Market - Key Company List by Country Premium
15. Radiopharmaceuticals/ Nuclear Medicine Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Advanced Accelerator Application
15.3 Bayer
15.4 Bracco Imaging
15.5 Cardinal Health
15.6 Curium
15.7 Eczacibasi-Monrol Nuclear Product
15.8 Ge Healthcare
15.9 Lantheus Medical Imaging
15.10 Nordion
15.11 Company 10
15.12 Company 11 & More
*Financials would be provided on a best efforts basis for private companies
16. Radiopharmaceuticals/ Nuclear Medicine Market - Appendix16.1 Abbreviations
16.2 Sources
17. Radiopharmaceuticals/ Nuclear Medicine Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Nuclear Medicine Market, By Type Market 2023-2030 ($M)1.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Global Industry Research
1.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
1.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
1.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Global Industry Research
1.2.1 Alpha Emitter Market 2023-2030 ($M)
1.2.2 Beta Emitter Market 2023-2030 ($M)
1.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
2.Global Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
2.1 Diagnostic Procedure Market 2023-2030 ($M) - Global Industry Research
2.2 Therapeutic Procedure Market 2023-2030 ($M) - Global Industry Research
3.Global Nuclear Medicine Market, By Type Market 2023-2030 (Volume/Units)
3.1 Diagnostic Nuclear Medicine Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Spect Radiopharmaceutical Market 2023-2030 (Volume/Units)
3.1.2 Pet Radiopharmaceutical Market 2023-2030 (Volume/Units)
3.2 Therapeutic Nuclear Medicine Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Alpha Emitter Market 2023-2030 (Volume/Units)
3.2.2 Beta Emitter Market 2023-2030 (Volume/Units)
3.2.3 Brachytherapy Isotope Market 2023-2030 (Volume/Units)
4.Global Nuclear Medicine Market, By Procedural Volume Market 2023-2030 (Volume/Units)
4.1 Diagnostic Procedure Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Therapeutic Procedure Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Nuclear Medicine Market, By Type Market 2023-2030 ($M)
5.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
5.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
5.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Alpha Emitter Market 2023-2030 ($M)
5.2.2 Beta Emitter Market 2023-2030 ($M)
5.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
6.North America Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
6.1 Diagnostic Procedure Market 2023-2030 ($M) - Regional Industry Research
6.2 Therapeutic Procedure Market 2023-2030 ($M) - Regional Industry Research
7.South America Nuclear Medicine Market, By Type Market 2023-2030 ($M)
7.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
7.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
7.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Alpha Emitter Market 2023-2030 ($M)
7.2.2 Beta Emitter Market 2023-2030 ($M)
7.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
8.South America Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
8.1 Diagnostic Procedure Market 2023-2030 ($M) - Regional Industry Research
8.2 Therapeutic Procedure Market 2023-2030 ($M) - Regional Industry Research
9.Europe Nuclear Medicine Market, By Type Market 2023-2030 ($M)
9.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
9.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
9.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Alpha Emitter Market 2023-2030 ($M)
9.2.2 Beta Emitter Market 2023-2030 ($M)
9.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
10.Europe Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
10.1 Diagnostic Procedure Market 2023-2030 ($M) - Regional Industry Research
10.2 Therapeutic Procedure Market 2023-2030 ($M) - Regional Industry Research
11.APAC Nuclear Medicine Market, By Type Market 2023-2030 ($M)
11.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
11.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
11.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Alpha Emitter Market 2023-2030 ($M)
11.2.2 Beta Emitter Market 2023-2030 ($M)
11.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
12.APAC Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
12.1 Diagnostic Procedure Market 2023-2030 ($M) - Regional Industry Research
12.2 Therapeutic Procedure Market 2023-2030 ($M) - Regional Industry Research
13.MENA Nuclear Medicine Market, By Type Market 2023-2030 ($M)
13.1 Diagnostic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Spect Radiopharmaceutical Market 2023-2030 ($M)
13.1.2 Pet Radiopharmaceutical Market 2023-2030 ($M)
13.2 Therapeutic Nuclear Medicine Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Alpha Emitter Market 2023-2030 ($M)
13.2.2 Beta Emitter Market 2023-2030 ($M)
13.2.3 Brachytherapy Isotope Market 2023-2030 ($M)
14.MENA Nuclear Medicine Market, By Procedural Volume Market 2023-2030 ($M)
14.1 Diagnostic Procedure Market 2023-2030 ($M) - Regional Industry Research
14.2 Therapeutic Procedure Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)2.Canada Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
3.Mexico Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
4.Brazil Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
5.Argentina Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
6.Peru Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
7.Colombia Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
8.Chile Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
9.Rest of South America Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
10.UK Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
11.Germany Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
12.France Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
13.Italy Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
14.Spain Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
15.Rest of Europe Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
16.China Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
17.India Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
18.Japan Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
19.South Korea Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
20.South Africa Radiopharmaceuticals/ Nuclear Medicine Market Revenue, 2023-2030 ($M)
21.North America Radiopharmaceuticals/ Nuclear Medicine By Application
22.South America Radiopharmaceuticals/ Nuclear Medicine By Application
23.Europe Radiopharmaceuticals/ Nuclear Medicine By Application
24.APAC Radiopharmaceuticals/ Nuclear Medicine By Application
25.MENA Radiopharmaceuticals/ Nuclear Medicine By Application
26.Cardinal Health, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Ge Healthcare, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Curium, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Lantheus Medical Imaging, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Bayer, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Bracco Imaging, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Eczacibasi-Monrol Nuclear Product, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Nordion, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Advanced Accelerator Application, Sales /Revenue, 2015-2018 ($Mn/$Bn)